449 related articles for article (PubMed ID: 26500074)
1. Designer exosomes as next-generation cancer immunotherapy.
Bell BM; Kirk ID; Hiltbrunner S; Gabrielsson S; Bultema JJ
Nanomedicine; 2016 Jan; 12(1):163-9. PubMed ID: 26500074
[TBL] [Abstract][Full Text] [Related]
2. Engineering Exosomes for Cancer Therapy.
Gilligan KE; Dwyer RM
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28538671
[TBL] [Abstract][Full Text] [Related]
3. Harnessing the exosome-induced immune response for cancer immunotherapy.
Gehrmann U; Näslund TI; Hiltbrunner S; Larssen P; Gabrielsson S
Semin Cancer Biol; 2014 Oct; 28():58-67. PubMed ID: 24859748
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell-derived exosomes as immunotherapies in the fight against cancer.
Pitt JM; Charrier M; Viaud S; André F; Besse B; Chaput N; Zitvogel L
J Immunol; 2014 Aug; 193(3):1006-11. PubMed ID: 25049431
[TBL] [Abstract][Full Text] [Related]
5. Exosomes for the treatment of human malignancies.
Viaud S; Ullrich E; Zitvogel L; Chaput N
Horm Metab Res; 2008 Feb; 40(2):82-8. PubMed ID: 18283625
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell-derived exosomes for cancer immunotherapy: what's next?
Viaud S; Théry C; Ploix S; Tursz T; Lapierre V; Lantz O; Zitvogel L; Chaput N
Cancer Res; 2010 Feb; 70(4):1281-5. PubMed ID: 20145139
[TBL] [Abstract][Full Text] [Related]
7. How can nanotechnology help membrane vesicle-based cancer immunotherapy development?
Tian X; Zhu M; Nie G
Hum Vaccin Immunother; 2013 Jan; 9(1):222-5. PubMed ID: 23108359
[TBL] [Abstract][Full Text] [Related]
8. Exosomes-Small Players, Big Sound.
Gulei D; Irimie AI; Cojocneanu-Petric R; Schultze JL; Berindan-Neagoe I
Bioconjug Chem; 2018 Mar; 29(3):635-648. PubMed ID: 29369619
[TBL] [Abstract][Full Text] [Related]
9. Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges.
Syn NL; Wang L; Chow EK; Lim CT; Goh BC
Trends Biotechnol; 2017 Jul; 35(7):665-676. PubMed ID: 28365132
[TBL] [Abstract][Full Text] [Related]
10. [The Functional Role of Exosomes in Cancer Biology and Their Potential as Biomarkers and Therapeutic Targets of Cancer].
Naito Y; Yoshioka Y; Ochiya T
Gan To Kagaku Ryoho; 2015 Jun; 42(6):647-55. PubMed ID: 26199235
[TBL] [Abstract][Full Text] [Related]
11. REMEDIAL APPLICATIONS OF EXOSOMES IN CANCER, INFECTIONS AND DIABETES.
Wang Q; Ding X; Zhen F; Ma J; Meng F
Acta Pol Pharm; 2017 Mar; 74(2):313-320. PubMed ID: 29624236
[TBL] [Abstract][Full Text] [Related]
12. Exosome-based tumor antigens-adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA.
Morishita M; Takahashi Y; Matsumoto A; Nishikawa M; Takakura Y
Biomaterials; 2016 Dec; 111():55-65. PubMed ID: 27723556
[TBL] [Abstract][Full Text] [Related]
13. Exosome-based anticancer vaccines: From Bench to bedside.
Zhao G; Wang Y; Xing S; Jiang Y; Ding J; Cai Y; Ma P; Miao H; Fang Y; Jiang N; Cui D; Yu Y; Tang Q; Wang S; Li N
Cancer Lett; 2024 Jul; 595():216989. PubMed ID: 38825162
[TBL] [Abstract][Full Text] [Related]
14. Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases.
Tran TH; Mattheolabakis G; Aldawsari H; Amiji M
Clin Immunol; 2015 Sep; 160(1):46-58. PubMed ID: 25842185
[TBL] [Abstract][Full Text] [Related]
15. Exosomes for immunotherapy of cancer.
Chaput N; Schartz NE; Andre F; Zitvogel L
Adv Exp Med Biol; 2003; 532():215-21. PubMed ID: 12908560
[TBL] [Abstract][Full Text] [Related]
16. The Biological Function and Therapeutic Potential of Exosomes in Cancer: Exosomes as Efficient Nanocommunicators for Cancer Therapy.
Choi JU; Park IK; Lee YK; Hwang SR
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33028046
[TBL] [Abstract][Full Text] [Related]
17. Cancer immunotherapy using dendritic cell-derived exosomes.
Amigorena S
Medicina (B Aires); 2000; 60 Suppl 2():51-4. PubMed ID: 11188932
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell-derived exosomes for cancer therapy.
Pitt JM; André F; Amigorena S; Soria JC; Eggermont A; Kroemer G; Zitvogel L
J Clin Invest; 2016 Apr; 126(4):1224-32. PubMed ID: 27035813
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell-derived exosomes in cancer immunotherapy: exploiting nature's antigen delivery pathway.
Delcayre A; Shu H; Le Pecq JB
Expert Rev Anticancer Ther; 2005 Jun; 5(3):537-47. PubMed ID: 16001959
[TBL] [Abstract][Full Text] [Related]
20. Review: cancer immunotherapy by exosome-based vaccines.
Hao S; Moyana T; Xiang J
Cancer Biother Radiopharm; 2007 Oct; 22(5):692-703. PubMed ID: 17979572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
